generics

FDA targets regulatory 'gaming' in effort to boost generic competition
FDA targets regulatory 'gaming' in effort to boost generic competition
BioPharma Dive
FDA
regulatory gaming
generics
competition
drug pricing
Scott Gottlieb
Flag link:
Increasing transparency on generic drug cost data could save $4 billion
Increasing transparency on generic drug cost data could save $4 billion
Modern Healthcare
generics
transparency
drug pricing
PBMs
Flag link:
Mylan's Copaxone copy could face another hold-up with FDA info request
Mylan's Copaxone copy could face another hold-up with FDA info request
Fierce Pharma
Mylan
Copaxone
FDA
generics
Teva Pharmaceutical
MS
multiple sclerosis
Flag link:
Pharma companies fight behind-the-scenes wars over generic drugs
Pharma companies fight behind-the-scenes wars over generic drugs
Stat
generics
Flag link:
FDA approves Teva's generic copy of Truvada
FDA approves Teva's generic copy of Truvada
BioPharma Dive
FDA
Teva Pharmaceutical
generics
Truvada
HIV
Gilead Sciences
Flag link:
Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
TheStreet.com
drug pricing
patents
patent cliffs
M&A
generics
Flag link:
Pharma Starts a Feedback Loop
Pharma Starts a Feedback Loop
Drug Patent Watch
patents
generics
patent expirations
patent cliffs
innovation
drug development
Flag link:
Lilly's Strattera faces first wave of generic competition
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Eli Lilly
Strattera
generics
ADHD
Apotex
Aurobindo
Glenmark
Teva Pharmaceutical
Flag link:
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Instant Analysis: Mallinckrodt Considering Sale of Generics Unit
Motley Fool
Mallinckrodt
generics
M&A
Flag link:
Another old, cheap generic is being prepped for an FDA application — made over into a ‘new’ drug for ADHD and narcolepsy
Another old, cheap generic is being prepped for an FDA application — made over into a ‘new’ drug for ADHD and narcolepsy
Endpoints
generics
FDA
NLS Pharma
ADHD
narcolepsy
Mazindol
Flag link:
[video]FDA to publish list of drugs with no generic competitor
[video]FDA to publish list of drugs with no generic competitor
Yahoo/CNBC
FDA
generics
competition
Flag link:
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
Sanofi Wins False Claims Case Appealed by Rival Drugmaker
Bloomberg
Sanofi
False Claims Act
Amphastar
generics
patents
Flag link:
The top 15 generic drugmakers by 2016 revenue
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
generics
Teva Pharmaceutical
Mylan Labs
Novartis
Pfizer
Allergan
Flag link:
Novartis pushes further into pain with Durect deal
Novartis pushes further into pain with Durect deal
BioPharma Dive
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Flag link:
FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!
FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!
FDA Law Blog
FDA
generics
Zithromax
exclusivity
Pfizer
Lupin
antibiotics
Flag link:
Merck's Vytorin set for massive sales slide as generics hit
Merck's Vytorin set for massive sales slide as generics hit
Fierce Pharma
Merck
Vytorin
generics
Teva Pharmaceutical
Impax Labs
Flag link:
FDA approves Impax generic of Merck's cholesterol drug Vytorin
FDA approves Impax generic of Merck's cholesterol drug Vytorin
Yahoo/Reuters
FDA
Impax Labs
generics
Merck
Vytorin
Flag link:
Fresenius Kabi picks up generic maker Akorn for $4.3B
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
M&A
generics
Fresenius
Akorn
Flag link:
Novartis' Gilenya patent loss sets MS market up for battle with early generics
Novartis' Gilenya patent loss sets MS market up for battle with early generics
Fierce Pharma
Novartis
Gilenya
MS
multiple sclerosis
generics
Flag link:
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
BMS and Pfizer file 16 Eliquis patent lawsuits to waylay generic makers
Fierce Pharma
Bristol-Myers Squibb
Pfizer
patents
Eliquis
patent lawsuits
generics
bloodthinners
Flag link: